- Target
- BCL11A
- Reactivity
- Human,Mouse
- Application
- WB
- MW(Calculated)
- 92kD
- MW(Observed)
- --
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Modification site
- --
- Recommended Dilution Ratio
- WB 1:500-2000
- Form
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source
- --
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Clone No.
- --
- Immunogen
- Synthesized peptide derived from human BCL11A
- Sequence
- --
- Specificity
- This antibody detects endogenous levels of BCL11A at Human, Mouse
- Gene Name
- BCL11A CTIP1 EVI9 KIAA1809 ZNF856
- Protein Name
- B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856)
- Other Name
- --
- Organism-1
- Human
- Gene ID-1
- 53335
- SwissProt-1
- Q9H165
- Organism-2
- Mouse
- Gene ID-2
- 14025
- SwissProt-2
- Q9QYE3
- Organism-3
- --
- Gene ID-3
- --
- SwissProt-3
- --
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cytoplasm . Nucleus . Chromosome . Associates with the nuclear body. Colocalizes with SUMO1 and SENP2 in nuclear speckles (By similarity). .; [Isoform 1]: Nucleus matrix . Colocalizes with BCL6 in nuclear paraspeckles. .; [Isoform 2]: Cytoplasm . Nucleus . Predominantly localized in the nucleus in nuclear paraspeckles. .; [Isoform 3]: Cytoplasm . Nucleus . Predominantly localized in the cytoplasm in the absence of interaction with isoform 1 and isoform 2. In presence of isoform 1 or isoform 2, translocates from the cytoplasm into nuclear paraspeckles. .